India's Strides Pharma Science jumps after Q3 profit rise
30/01/2025 10:01
** Shares of Strides Pharma Science SRID.NS rise 7.1% to
651.95 rupees
** Co's Q3 consolidated net profit jumped 77.1% y/y, revenue
rose 14.7%
** Trading vols at 4.2 mln shares, nearly 6x the 30-day
average
** SRID more than doubled in 2024
(Reporting by Vijay Malkar)
((VijayDattaram.Malkar@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees